TLR6 and metabolic dysfunction-associated steatohepatitis: These data suggest a role for TLR2/TLR6 dependent signaling in the pathogenesis of NASH with deregulated TLR6 potentiating TLR2/TLR6 downstream activity in morbidly obese patients, although this finding needs to be further confirmed on a larger sample size study.